The HNRNPH2-associated disease (mental retardation, X-linked, syndromic, Bain type [MRXSB, MIM #300986]) is caused by de novo mutations in the X-linked HNRNPH2 gene. MRXSB has been described in six female patients with dysmorphy, developmental delay, intellectual disability, autism, hypotonia and seizures. The reported HNRNPH2 mutations were clustered in the small domain encoding nuclear localization signal; in particular, the p.Arg206Trp was found in four independent de novo events. HNRNPH1 is a conserved autosomal paralogue of HNRNPH2 with a similar function in regulation of pre-mRNAs splicing but so far it has not been associated with human disease. We describe a boy with a disease similar to MRXSB in whom a novel de novo mutation c.616C>T (p.Arg206Trp) in HNRNPH1 was found (ie, the exact paralogue of the recurrent HNRNPH2 mutation). We propose that defective function of HNRNPH2 and HNRNPH1 nuclear localization signal has similar clinical consequences. An important difference between the two diseases is that the HNRNPH1-associated syndrome may occur in boys (as in the case of our proband) which is well explained by the autosomal (chr5q35.3) rather than X-linked localization of the HNRNPH2 gene.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/cge.13410 | DOI Listing |
Mov Disord
January 2025
ALEA Neurotechnology Research and Development Company, Ankara, Türkiye.
Background: Essential tremor (ET) is a common type of tremor. Previous research has shown that wearable orthoses and biomechanical loading methods can suppress tremors.
Objective: This study aims to investigate the effect of a harmonic liquid dampener on upper extremity ET.
JAMA Netw Open
January 2025
Center for OCD and Related Disorders, Massachusetts General Hospital, Boston.
Importance: Obsessive-compulsive and related disorders (OCRDs) encompass various neuropsychiatric conditions that cause significant distress and impair daily functioning. Although standard treatments are often effective, approximately 60% of patients may not respond adequately, underscoring the need for novel therapeutic approaches.
Objective: To evaluate improvement in OCRD symptoms associated with glutamatergic medications as monotherapy or as augmentation to selective serotonin reuptake inhibitors, with a focus on double-blind, placebo-controlled randomized clinical trials (RCTs).
Diabetes Obes Metab
February 2025
Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.
Background: People hospitalised for coronavirus disease 2019 (COVID-19) have elevated incidence of diabetes. However, it is unclear whether this is due to shared risk factors, confounding or stress hyperglycaemia in response to acute illness.
Methods: We analysed a multicentre prospective cohort study (PHOSP-COVID) of people ≥18 years discharged from NHS hospitals across the United Kingdom following COVID-19.
Environ Sci Pollut Res Int
November 2024
Department of Civil Engineering, Jadavpur University, Kolkata, India, 700032.
Mangroves serve as biotic fences of estuarine belts consisting of salt-tolerant plants that grow in intertidal zones and can be regenerated naturally as well as artificially. Mangrove regeneration refers to the process of restoring or rebuilding mangrove ecosystems that have been already degraded, damaged, or lost from their native place through the monitoring of geomorphological, taxonomical, pedological, and ecological aspects. The primary objective of this study was based on the remote sensing application through several important health monitoring indices over the minute part of Indian Sundarbans to prove the possibility of mangrove regeneration.
View Article and Find Full Text PDFDiabetes Ther
November 2024
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Introduction: The high risk of cardiovascular events in people with type 2 diabetes increases with age. The cardiovascular effects of once-weekly subcutaneous and once-daily oral semaglutide versus placebo in people with type 2 diabetes at high cardiovascular risk were investigated in the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials, respectively. It is unknown whether the effects of semaglutide are age dependent.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!